enVVeno Medical Corporation (NASDAQ:NVNO) Stock Plunged -33.07% So Far In 2024, What Analysts Expect Next?

In recent trading session, enVVeno Medical Corporation (NASDAQ:NVNO) saw 0.91 million shares changing hands at last check today with its beta currently measuring 1.23. Company’s recent per share price level of $3.44 trading at -$1.06 or -23.56% at last check today assigns it a market valuation of $45.86M. That most recent trading price of NVNO’s stock is at a discount of -102.62% from its 52-week high price of $6.97 and is indicating a premium of 1.16% from its 52-week low price of $3.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 65980.0 shares which gives us an average trading volume of 49.97K if we extend that period to 3-months.

enVVeno Medical Corporation (NASDAQ:NVNO) trade information

Upright in the red during last session for losing -23.56%, in the last five days NVNO remained trading in the red while hitting it’s week-highest on Monday, 09/23/24 when the stock touched $3.44 price level, adding 30.36% to its value on the day. enVVeno Medical Corporation’s shares saw a change of -33.07% in year-to-date performance and have moved -27.58% in past 5-day. enVVeno Medical Corporation (NASDAQ:NVNO) showed a performance of -35.22% in past 30-days. Number of shares sold short was 0.8 million shares which calculate 16.77 days to cover the short interests.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

enVVeno Medical Corporation (NVNO) estimates and forecasts

Statistics highlight that enVVeno Medical Corporation is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -36.76% of value to its shares in past 6 months, showing an annual growth rate of 31.94% while that of industry is 13.20. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 46.51% during past 5 years.

enVVeno Medical Corporation (NASDAQ:NVNO)’s Major holders

Insiders are in possession of 0.38% of company’s total shares while institution are holding 25.06 percent of that, with stock having share float percentage of 25.15%. Investors also watch the number of corporate investors in a company very closely, which is 25.06% institutions for enVVeno Medical Corporation that are currently holding shares of the company. KINGDON CAPITAL MANAGEMENT, L.L.C. is the top institutional holder at NVNO for having 0.65 million shares of worth $3.43 million. And as of 2024-06-30, it was holding 4.0722 of the company’s outstanding shares.

The second largest institutional holder is PERCEPTIVE ADVISORS LLC, which was holding about 0.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.8819 of outstanding shares, having a total worth of $3.27 million.